What evidence supports the use of 5-ASA compounds in treating microscopic colitis, specifically lymphocytic colitis?

Tripdatabase

Open source

DOI
10.5281/zenodo.20584019
Published
2026
Container
Not recorded
Publisher
Zenodo
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.20584019,
  title = {What evidence supports the use of 5-ASA compounds in treating microscopic colitis, specifically lymphocytic colitis?},
  author = {Tripdatabase},
  year = {2026},
  doi = {10.5281/zenodo.20584019},
  url = {https://doi.org/10.5281/zenodo.20584019}
}

RIS

TY  - JOUR
TI  - What evidence supports the use of 5-ASA compounds in treating microscopic colitis, specifically lymphocytic colitis?
AU  - Tripdatabase
PY  - 2026
DO  - 10.5281/zenodo.20584019
UR  - https://doi.org/10.5281/zenodo.20584019
ER  - 

APA

Tripdatabase (2026). What evidence supports the use of 5-ASA compounds in treating microscopic colitis, specifically lymphocytic colitis?. https://doi.org/10.5281/zenodo.20584019

Source records